Skip to content
value.today

BioStem Technologies, Inc. vs Celularity Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • BioStem Technologies, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 29, 2026 for BioStem Technologies, Inc. and Oct 30, 2026 for Celularity Inc.).
  • BioStem Technologies, Inc. had more revenue: $47 M against $27 M for Celularity Inc., both in the year to December 2025.
  • Both made a net loss: $7 M for BioStem Technologies, Inc. and $92 M for Celularity Inc.
  • BioStem Technologies, Inc. keeps more of each dollar of sales: a net margin of -13.9% against -345.5% for Celularity Inc.
  • BioStem Technologies, Inc.'s revenue grew faster in its latest fiscal year: -31.8% against -51.0% for Celularity Inc.
  • Their Altman Z-scores put BioStem Technologies, Inc. in the grey zone and Celularity Inc. in the distress zone.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

01432854285702023202420252026BioStem Technologies, Inc. 290Celularity Inc. 5

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B20212022202320242025BioStem Technologies, Inc. $0BCelularity Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBioStem Technologies, Inc.
BSEM · #23,187 in the world
Celularity Inc.
CELU · #23,307 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$29 M$28 M
Revenue$47 M$27 M
Net income$-7 M▲ best$-92 M
Employees—288
Valuation
Price to sales0.7×1.5×
Price to book0.7×—
Free cash flow yield22.8%▲ best-23.8%
Profitability
Gross margin93.6%▲ best24.4%
Operating margin-1.4%▲ best-230.9%
Net margin-13.9%▲ best-345.5%
Return on equity-16.6%—
Growth
Revenue growth-31.8%▲ best-51.0%
Revenue growth, 3 years a year—13.9%
Financial strength
Debt to equity0.0×—
Cash
Free cash flow margin13.9%—
Strength scores
Piotroski F-score5 of 9—
Altman Z-score zonegreydistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, BioStem Technologies, Inc. or Celularity Inc.?

BioStem Technologies, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 29, 2026 for BioStem Technologies, Inc. and Oct 30, 2026 for Celularity Inc.).

Which makes more money, BioStem Technologies, Inc. or Celularity Inc.?

BioStem Technologies, Inc. had more revenue: $47 M against $27 M for Celularity Inc., both in the year to December 2025. Both made a net loss: $7 M for BioStem Technologies, Inc. and $92 M for Celularity Inc.

Which is more profitable, BioStem Technologies, Inc. or Celularity Inc.?

BioStem Technologies, Inc. keeps more of each dollar of sales: a net margin of -13.9% against -345.5% for Celularity Inc.

Which is growing faster, BioStem Technologies, Inc. or Celularity Inc.?

BioStem Technologies, Inc.'s revenue grew faster in its latest fiscal year: -31.8% against -51.0% for Celularity Inc.

Which is financially stronger, BioStem Technologies, Inc. or Celularity Inc.?

Their Altman Z-scores put BioStem Technologies, Inc. in the grey zone and Celularity Inc. in the distress zone.

Sources#

Every figure on this page comes from these, with the date shown next to it.